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A recently described mammalian wound hyaluroni-
dase is successfully characterized and partially purified 
in the current study. Peak enzyme activity occurred on 
postwound day 7, pH optimum 4.5. Both crude and pu-
r ified wound enzyme exhibited endoglycosidic activity 
against hyaluronate and chondroitin-4-sulfate but not 
against chondroitin-6-sulfate or derma tan sulfate. A 5.3-
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fold increase in activity was obtained by the DEAE-
Sephadex purification technique described. Polyacryl-
amide gel electrophoresis yielded a single major band 
near the gel's midrange and one minor band of lesser 
electrophoretic mobility. These enzyme characteristics 
support a- biochemical analogy, b etween .tissue repair in 
skin and numerous developmental systems and may also 
provide a simple means for enzymatic differentiation 
among chondroitin sulfate isomers. 
In mammalian wound repair, early cellular proliferation and 
ground substance synthesis are followed by the resorptive and 
remodelling processes which collectively constitute wound 
"maturation." Mechanisms which control the collagenous, cel-
lular, and glycosaminoglycan (GAG) composition of wound 
granulation t issue remain unknown. 
Balazs and Holmgren [1] suggested t hat wound granulation 
t issue contained predominantly nonsulfated GAG during the 
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ini t ial 4 days of healing which were later replaced by sulfa ted 
polysaccharides. They proposed that this transition mediated 
both fibroblast proliferation in early wounds and collagen pro-
duction later. Bentley [2] studied the GAG of open skin wound 
granulation t issue and found that chondroitin-4-sulfate and 
dermatan sulfa te increased from day 5 to day 17, while the 
nonsulfated GAG, h yalmonic acid, remained fairly constant 
after an ini tial fall from day 5 to day 10. Similar changes in 
ground substance from nonsulfa ted to sulfated forms have been 
repor ted in healing tendon [3] and in cornea [4]. Toole et al [5-
8] have suggested that hyaluronate metabolism may be in-
volved in the regulation of cell behavior; hyaluronic acid syn-
thesis has been associated with cellular proliferation and migra-
tion, while its enzymatic removal by hyaluronidase has been 
correlated with cytodifferentia tion. Historically, numerous par-
allels have been drawn between developmental systems and the 
process of wound healing, yet only recently h ave preliminary 
data been obtained for wound hyaluronidase activity [9]. In the 
current study, t his open skin wound granula tion tissue h yalu-
ronidase has been further characterized and a partial pW'ifica-
tion achieved. 
MATERIALS AND METHODS 
Wounding 
Fifty-e ight 2.0-3.0 kg New Zeala nd whi te rabbi ts were caged sepa-
rate ly and maintained on an Agway ra bbi t chow diet with food a nd 
water taken ad lib. Rabbi ts were anesthetized wi th intra venous sodium 
pentobarbital (Diabutal, D iamond Laboratories, Inc.) and the flanks 
shaved and dep ilated with Nair depilatory. A single 6 X 6 cm wound 
was made on the left and right fl ank of each animal. Skin and superficial 
fascia were excised to the level of the panniculus carnosus muscle with 
about 50% of each wound overlaying the rib cage. Resected skin was 
frozen and retained as a normal control. Dressings consisted of Vaseline 
gauze, gauze ro ll, and a light plaster cast. 
Wound A rea Determinations 
At wounding and harvesting, wound tracings were made on tra nslu-
cent paper and surface areas determined fro m th e trac ings by compen-
sating polar planimetry. MeasuTed decreases in wound surface a rea 
could be attribu ted specifically to wound contrac tion since all measure-
ments were based upon the original wound margins and not upon the 
new margins created by migrating epi thelium. 
Sampling 
A diffe rential wound topography permi ts recogni t ion of two distinct 
zones. Mo t of the open defect conta ins a granulation tissue filling 
which is referred to as "central granulation tissue." Along the wound's 
periphery, between central granula tion t issue a nd the original un-
wounded skirr, a- bipartite zone ex ists which is composed of a deep layer 
of granulation t issue and a superlicia l sheet of migrating epithelium. 
This bilayered region constitutes "whole edge tissue." Samples of 
central gra nulations, whole edge tissue, and skin 1 cm anterior to the 
cephalad wound edge midpoint were harvested. Sampling was per-
formed on postwound days 4,7, 13, 14,15, and 19; t issues were pooled 
on the basis of tissue type and postwound day. 
Tissue Prep aration and S torage 
Ini t ia lly, t issues were harvested, frozen, and stored at -20°C until 
needed. At the time of analysis the tissue was thawed, minced in 0.05 
M sodium acetate, 0.05 M NaCI, pH 4.5 (acetate buffer) , and homoge-
nized in a Wari ng blender. R esul ting homogenates possessed large 
tissue fTagments that made random sampling difficul t, so an alternative 
preparation was util ized whereby ha rvested tissues were frozen in Liquid 
nitrogen, lyophilized, milled, and t hen stored at 4°C until required . 
Unless otherwise indicated, the second method was used in a Li assays 
described. 
Hyalu.ronidase and Hyaluron a.te Assays 
Wound tissue hya lw-onidase activity and hyaluronate conten t were 
determined by measuring release of terminal N-acetylhexosamine in 
the manner described in a preliminary repor t [9]. H exuronic ac id was 
assayed by the method of Bit ter and Muir [10] using a glucul"Onic ac id 
standard. 
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Cham cteristics of Crude W ound Hyaluronidase 
The pH optimum was determined over the range 3.0-6.6. The 
specificity of the colorimetric assay for terminaJ N-acetylhexosamine 
was evaluated by comparing the spectra of samples to the spectrum of 
an N-acetylglucosamine standard in the range 500-600 nm. 
T o exclude the possibili ty of rate Limita tion due to insuff icient 
exogenous hyaluronate, incubations of enzyme homogenate were per-
formed at the following substrate concentrations: 0.04 mg/ ml, 0.08 mg/ 
ml, 0.1 mg/ml, 0.3 mg/mI, 0.4 mg/ ml, and 0.8 mg/ml. 
The percentage of released terminal N-acetylhexosamine that is 
specifically attribu table to endoglycosidase ac tivity was measured by 
inhibiting the exoglycosidases, /J-N-acety lglucosaminidase, and /J-glu-
curonidase, with saccharo-l,4-lactone monohydra te (Calbiochem, La 
J olla, California). A saccharolactone concent ra tion of 1.5 mM was 
employed in finaJ incubation mixtures of crude enzyme preparations 
derived from 14- and 15-day open wound granulation tissue [11]. 
The substra te specificities of crude enzyme preparat ions were ascer-
tained by preparing incubation mix tures as described but wi th hyalu-
ronate being replaced by 200 fJ.g of chondroitin-4-sulfate (Sigma St. 
Louis, Missouri ), chondroitin-6-sulfate (S igma), or dermatan sulfa te 
(Sigma). 
A pre liminary reaction product analysis was performed by incubating 
equivalent amounts of wound enzyme or testicula r hyaluronidase with 
hyaluronic acid for 16 hr. P roducts were precipitated with 1% potassium 
aceta te and ethanol, and th en dried and lyophilized . The result ing 
powder was dissolved in water and chromatographed on Whatma n No. 
1 paper for 40 hr with butanol:ace tic ac id:water, 44:16:40, in a descend-
ing system. H exosamine-containing ma terial was located wi th an E lson-
Morgan spray [12]. Papers were a lso examined beneath 232- nm ultra-
violet light for unsaturated products. 
Hyaluronid a.se Iso lation and Purification 
Crude enzyme preparations from 14-day open wound granulation 
tissue were centrifuged at 42,000 X g for 20 min, the supernatants 
decanted, and the pellets suspended in formate bu ffer. Aliquots of 
supernatant and pelle t suspension were removed, their respective spe-
cific activities calculated, and the remaining supernatant dialyzed 
against 2 changes of cold phosphate buffer (0.02 M, pH = 6.0, fJ. = 0.08). 
Anion exchange chromatography of the supernatant was performed 
using phosphate buffer elution over DE AE-Sephadex at 4°C in the 
manner described by Som and Ionescu-Stoian [13]. T o a 20 X 80 mm 
colu mn of DE AE-Sephadex (A-50, medium, 100-200 mesh, excha nge 
capacity = 3.1 meq/g) was added 5.2 ml of supernatant. The column 
was run at a fl ow of 0.5 ml/min a nd 6-ml fractions were collected. 
Fractions were dialyzed against cold distilled wa ter, lyophilized, sus-
pended in 2 ml of formate buffer, and specific activi ties calculated. A 
0.38 M NaCI solution was then used to elu te additional protein from the 
column. Eluate was dialyzed against cold distilled water , lyophilized, 
and the specific activi ty determined in formate buffer. The ac tivity of 
pw-ifled enzyme against chondroitin-4-sulfate, chondroit in-6-sulfate , 
and de rma tan sulfate substra tes in addi t ion to hyaluronic ac id was 
measured. Polyacyla mide gel electrophoresis (P AGE) was performed 
on a liqu ots of crude, supernatant, and pW'ified materia l. 
RESULTS 
Identification and Localization of Wound Hyaluronidase 
The identification of a hyaluronidase-like enzyme in open 
wound granulation tissue subsequent to postwound day 7 has 
been reported in a preliminary study [9]. No enzyme activity 
was detected in open wound granulation tissue before day 7 
(i.e. , a t day 4). In the pl'esent work, hyaluronidase activity was 
a bsent from whole edge tissue prior to postwound day 14 (i. e., 
a t days 4, 7, and 13); however, whole edge hyaluronidase activ-
ities were compara ble to those measured in central granula tion 
tissue a fter 14 days. No activity could be detected in normal 
ra bbit skin. 
H yaluronic acid increased from 8 t-tg/ lOO mg wet weigh t at 5 
days to 47 t-tg/ 100 mg wet weight at 9 days and then decreased 
to 13 /-tg/ lOO mg wet weight at 14 days. At day 9, the amount of 
hyalmonic acid in the edge was 3 times tha t of central granu-
lation tissue (133 /-tg hyaluronate/lOO mg wet weight) . 
Spectra obtained in colorimetric hyaluronate and hyaluroni-
dase determinations were similar to those for N -acetylglucosa-
mine standards (Fig 1) . Maximal absorbances occurred at ap-
proximately 545 and 580 nm. 
Dec. 1982 
C haracterization of Crude Wound Hyaluronidase 
The pH optimum of crude enzyme homogenate in formate 
buffer was found to be 4.5 with enzymatic activity measurable 
from pH 3.7 to pH 5.1 (Fig 2). The amount of terminal reducing 
N-acetylglucosamine released in incubation mixtures was not 
influenced by hyaluronic acid concentrations over the range of 
0.04-0.8 mg/ml. Clearly, the concentration of hyaluronic acid 
used in all other experiments (0.4 mg/ml) was not a rate-
limiting factor. 
Fourteen-day granulation tissue hyaluronidase was more ac-
t ive against hyalmonic acid and chondroitin-4-sulfate than 
against chondl'oitin-6-sulfate or derma tan sulfate (Table I). The 
difference in enzyme activity between a hyaluronic acid sub-
strate and a chondroitin-4-sulfate substrate was statistically 
insignificant by a t test for independent variables (0.3 < p < 
0.4) while t he difference in activity between hyaluronic acid 
a nd chondroitin-6-sulfate substrates was statistically significant 
at the 0.02 < P < 0.05 level. 
Inclusion of 1.5 mM saccharo-1,4-lactone monohych'ate did 
not significantly influence release of terminal reducing N-ace-
tylhexosamine. 
Examination of 16-hr digestion products by paper chl"oma-
tography did not reveal ultraviolet-absorbing spots indicative 
of unsaturated products. No products were seen in digests when 
e nzyme had been boiled initially; the N-acetylglucosamine 
l 50 
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FIG 1. Comparison of spectra of N-acetylhexosamine-derived 
chromogen of N-acetylglucosamine sLandru'd (curve A) a nd of 9-day 
whole edge tissue extract, incubated with S treptomyces hyaluronidase 
(curve B). Curve B corrected for absorbance of boi led bla nk control. 
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FIG 2. pH Optimum of crude, 14-day open wound granulation tissue 
hyaluronidase in 0.01 M sodium formate, 0.15 M NaCI, 0.1% Triton x-
100 buffer. Hyaluronidase uni ts al'e defined to be fLg N-acetylhexosa-
mine released pel' mg Lowry protein per 8 hI', 37°C incubation. 
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TABLE I. S ubstrate specificity of 14· day open wound granulation 
tissue hyaluronidase 
Substrate" 




Units enzyme activity ± S.E" 
1.4 ± 0.35 
1.0 ± 0.13 
0.3 ± 0.04 
0.2 ± 0.01 
" Incubation mixtm es contained 200 fLg of the indicated substrate; 
250 fLl enzyme prepru'ation contained in 0.01 M sodium formate, 0.15 M 
NaCI, and 0.1% Triton X-lOO buffer, pH 4.5. 
I, One uni t of enzyme activity is defined to be 1.0 fLg N-acetylhex-
osamine released per 1.0 mg Lowry protein per 8 hI', 37°C incubation. 
TABLE II. Pl./.rification of 14·day open wound granulation tissue 
hyaluronidase" 
Total Total Enzyme % Enzyme Units En7.ynle preparation specific protein" activ ity' activity activity' 
Crude 230.0 411.7 100.0 1.8 
Supernatant 58.8 71.1 17.3 1.2 
Pellet 171.2 125.0 30.4 0.7 
Column sample 52.7 63.8 15.5 1.2 
DEAE-Sephadex 
(enzyme peak) 4.4 28.1 6.8 6.4 
DEAE-Sephadex 
(non-peak [x) 2.7 0 0 0 
0.38 M NaCI elution 27.8 0 0 0 
" FouTteen-day tissue refers to open wound central granulation tissue 
har vested on postwound day 14. 
" Milligrams protein. 
,. One unit of enzyme activity is defined to be 1.0 fLg N-acetylhex-
osamine released per 1.0 mg Lowry protein per 8 hr, 37°C incubation. 
products of non boiled wound enzyme were identical to those 
produced by testicular hyalmonidase. 
Enzyme I solation and Partial Purification 
Table II demonstrates that a partial pmification could be 
achieved that resulted in a 5.3-fold increase in specific activity. 
The effectiveness of enzyme solubilization by the formate buffer 
can be seen by comparing th e percentage of total protein 
retained in the supernatant after ultracentrifugation to the total 
enzyme activity retained. Seventeen percent of total crude 
enzyme activity remained in t he supernatant, yet the superna-
tant's specific activity was approximately 67% that of the crude 
enzyme; therefore, the formate buffer appears to solubilize 
enzyme less readily than it does overall t issue protein. Although 
a substantial specific activity increase was achieved using this 
paltial pmification, the final pmified material contained only 
7% of the total activity of th e crude preparation. Possible 
reasons for loss of enzyme activity will be discussed subse-
quently. The purified material contained approximately 2% of 
t he protein of the crude homogenate. 
Enzyme activity eluted at a volume of 13-18 mI. No activity 
was found in non-peak fractions nor in the protein eluted by 
0.38 M NaC!. 
PAGE of enzyme homogenates exhibited a prominent band 
which migrated to a level just beyond the gel's midpoint (Fig 
3) . When the active DEAE-Sephadex fraction was electropho-
resed, only 2 bands could be identified: the major band corre-
sponded to the most prominent band of t he supernatant and 
crude enzyme gels; th e minor band was less distinct and of 
lower mobili ty. 
The partially pmified hyalmonidase was inactive against 
chondroitin-6-sulfate and dermatan sulfate (Table Ill) . The 
level of activity toward chondroitin-4-sulfate was only one-third 
of that toward hyaluronic acid. 
Enzyme prepru'ations dialyzed against fOl'mate buffer at pH 
3.0, 3.5, 3.7, 4.0, 4.5, and 6.0 became totally inactive. Possible 
reasons for inactivation will be discussed. 
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a b 
FIG 3. a., Seven percent polyacrylamide/1% sodium dodecyl sulfate 
gels of crude and partially purified 14-day open wound granulation 
tissue hyaluronidase. Gels 1-3: 25 /iI, 50 Il l , 25 /il of crude wound extract, 
a lso see Table II. Gels 4-6: 25 /iI, 50 /iI, 25 /il of wound extract 
supernatant, also see Table n. b, Unlabeled gels (left to right): 10 /iI, 25 
/il of 13-18 ml void volume fraction from DEAE-Sephadex chromatog-
raphy of wound extract supernatant. 

















" T he crude and pUl'ified enzyme preparations were made from two 
separate lots of 14-day open wound granulation tissue; as a result, 
compariso,:!s between the two types of enzyme extracts for a given 
substrate cannot be made. Proper interpretation requires that compar-
isons be made only within a single category of enzyme preparation (i.e., 
crude or purified). 
" The specific activity of the crude enzyme preparation from wh ich 
the indicated purified activity of 3.4 was derived equalled 0.82, not 1.4. 
T his difference is attributable to variabili ty among different tissue 
enzyme preparations. 
DISCUSSION 
A hyaluronidase-like enzyme has been found in healing 
wound granulation tissue by postwound day 7. The absence of 
enzymatic activity during the first week after wounding might 
favor an accumulation of unsulfated GAG in the manner de-
scribed earlier [1,2]. 
The fact that the amount of hyaluronate in wound granula-
tion tissue was 50% higher at POiltwound day 7 than at post-
wound day 14, suggests a functioning degradative system during 
the second week of healing. Since the observed changes in 
hyaluronate are in agreement with those obtained by Bentley 
[2], it appears that Str:eptomyces hyaluronidase is useful in 
providing an approximate hyaluronate content that can be 
correla ted to hyalmonidase activi ty. In the current study, N-
acetylhexosamine released as a result of treatment with Strep-
tomyces hyaluronidase reflects only hyaluronic acid since (1) 
the fungal enzyme has a well-documented monospecificity for 
hyillW'onic acid [14,15]; (2) boiled tissue blanks were included 
in all analyses to control for free or nonenzymatically released 
N-acetylhexosamine; and (3) enzymatically released N-acetyl-
hexosamine was not maximal immediately after wounding, but 
rather increased gradually through out the first postwound 
week. 
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In whole edge tissue, enzyme activi ty was not present until 
relatively late (14 days). DUl'ing its absence, hyaluronic acid 
levels were quite high; for example, at 9 days, the hyaluronate 
content of hyaluronidase-positive central granulation t issue was 
one-third that of the corresponding hyaIUJ'onidase-negative 
whole edge tissue. 
In developmental systems [5-8,16] the level of sulfated GAG 
increases as the amount of hyaluronate decreases. A similar 
phenomenon is suggested for the healing wound by the more 
t han 5-fold increase in central granulation tissue uronic acid 
between days 7 and 14 accompanied by a marked drop in 
hyaluronate [9]. The increasing level of uronic acid cannot be 
attributed to hyalmonate so the most likely source would be 
sulfated GAG, e.g., dermatan sulfate and/ or chondroitin sul -
fates. Since such sulfated substances are characteristically the 
products of differentiated cells, it appears that hyaluronate 
degradation by hyalUl'onidase is contemporary with cellular 
differentiation. Whether or not hyalUl'on idase resorption of 
hyalm onic acid ini tiates the process of differen tiation remains 
purely speculative, but the sequence of events operative in 
healing wounds appears similar to that described for develop-
mental systems. 
The crude enzyme's pH optimum of 4.5 is within the range of 
optima described for other mammalian hyaluJ'onjdases [19,20]. 
Although the cell responsible for manufacture and secretion of 
wound hyaluronidase is not known, the pH optimum suggests 
that neither acute nor chronic inflammatory cells are involved 
since leukocytic hyaluronidase has been reported to have a pH 
optimum of 3.7 [21]; Goggins, Lazarus, and Fullmer [22] ob-
served a pH optimum of 3.9 for rabbit macrophage hyaluroni-
dase, and Tsuda et al [23] failed to detect any hyalUl'onidase 
activity whatsoever in rabbit polymorphonuclear leukocytes. 
Furthermore, activity was maximal in the virtual absence of 
inflammatory infiltrates in the current study. The lack of un-
saturated products makes a bacterial origin for the hyaluroni-
dase activity remote. 
An attempt to determine the pH optimum of partially pmi-
fi ed enzyme was unsuccessful since no activity could be detected 
at any pH value tested (including 4.5) . The final dialysis em-
ployed for pH adjustment appears to be the cause of inactiva-
tion since all preparations had been active prior to dialysis. 
The hyalw'onidase-type enzymes range from being extremely 
narrow in their spectrum of activity to being quite broad. Crude 
and partially pUl'ified wound enzyme exhibi ted activity against 
hyaluronic acid and chondroitin-4-sulfate but not against chon-
droitin-6-sulfate or deJ'matan sulfate. AppaJ'ently desulfation 
occUJ'S during the COUl'se of the reaction against ch ondl'Oi tin-4-
sulfate since substitu tion in the 4 position would in terfere with 
the formation of the in termediate required for color develop-
ment (presumably a glucoxazoline) [24]. The abili ty to differ-
entiate between chondroitin-4-sulfate and chondroitin-6-sulfate 
is a property shared by a tadpole skin hyaluronidase described 
by Silbert and DeLuca [25]; however, the tadpole enzyme does 
not involve an associated desulfation of chondroitin-4-sulfate . 
Polyacrylamide gels of partially purified enzyme apperu' sim-
ilar to those obtained by Yang and Srivastava [20) for bull 
sperm hyal uronidase that was purified by means of DEAE-
cellulose, Sephadex G-200, and concanavalin-A Sepharose 4B 
afi1nity chromatography and for ram sperm hyalul'onidase pu-
rified by gel filtration and DEAE-cellulose chromatography 
[26]. A major and minor band were identified by PAGE wi th 
the hyaluronidase activity being associated with the major 
band. 
Formate buffer has been shown to inhibit exoglycosidase 
action in other experimental systems [19]. To assw'e that thjs 
buffer possessed the same capacity for wound tissues, a known 
inhibitor of exoglycosidases, saccharo-1,4-lactone monohydrate 
[11], was included in incuba tion mixtmes. Since enzyme activ-
ities measUl'ed in the absence of saccharolactone were no 
greater than those measured in its presence, formate buffer was 
Dec. 1982 
considered to be an effective inhibitor of exoglycosidases; con-
sequently, all activity measm ed by the release of N-acetylhex-
osamine appears attributable to endoglycosidic action. 
LabiJity toward manipulative procedmes such as dialysis, 
shaking, and contact with glass containers is characteristic of 
other hyalmonidases [27]. Nonetheless, a 5.3-fold increase in 
hyalmonidase specific activity was obtained with the partial 
purification of the current study. 
Upon DEAE-Sephadex chromatography, the enzyme eluted 
into the void volume while nonactive proteins were retained on 
the column. Fractions eluted by 0.38 M N aCI solution exhibited 
no enzymatic activity despite a total protein content of 27.8 mg. 
P AGE of enzyme preparations revealed that the degree of 
pUl"ification accomplished by DEAE-Sephadex chromatogm-
phy approximated that of the more elaborate procedmes ap-
plied to other mammalian hyalmonidases [20,26]' 
Gratitude is expressed to John McK. Snowden, Ph.D. for useful 
suggestions and textual criticisms and to Carol Kaine for assistance in 
manuscript prepamtion. 
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